By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous uncategorized agents > Hemgenix
Miscellaneous uncategorized agents

Hemgenix

https://themeditary.com/drug/hemgenix-361.html
Medically Reviewed by Judith Stewart, BPharm TheMediTary.Com | Reviewed: Jul 10, 2023  Additional Content by TheMediTary.Com

Generic name: etranacogene dezaparvovec-drlb

Drug class: Miscellaneous uncategorized agents

Dosage form: suspension, for intravenous infusion

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Etranacogene dezaparvovec (monograph)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Hemgenix?

Hemgenix is a one-time gene therapy for the treatment of adults with hemophilia B.

Hemophilia B is an inherited bleeding disorder resulting from missing or insufficient levels of blood clotting Factor IX, a protein needed to produce blood clots to stop bleeding.

Hemgenix consists of a viral vector that carries a gene for Factor IX. The gene is expressed in the liver to produce the Factor IX protein, which increases the blood levels of Factor IX to limit episodes of bleeding. 

What is Hemgenix used to treat?

Hemgenix is used to treat hemophilia B in adults who currently use Factor IX prophylaxis therapy, or who have current or historical life-threatening bleeding, or who have repeated, serious spontaneous bleeding episodes.

Symptoms of hemophilia B can include prolonged or heavy bleeding after an injury, surgery, or dental procedure; or may even occur spontaneously in severe cases. Prolonged bleeding episodes can lead to serious complications, such as bleeding into joints, muscles or internal organs, including the brain. 

Hemgenix works to reduce the rate of annual bleeds in hemophilia B patients, and reduce or eliminate the need for prophylactic therapy by generating elevated and sustained factor IX levels for a period of years after a one-time infusion.

Warnings

Hemgenix may cause serious side effects, including:

Infusion reactions. Signs and symptoms of infusion reactions may include:

  • chest tightness
  • headaches
  • abdominal pain
  • lightheadedness
  • flu-like symptoms
  • shivering
  • flushing
  • rash, and
  • elevated blood pressure.

You will need to be monitored while you are receiving the infusion, and for at least 3 hours after. If a reaction occurs, the infusion rate may be slowed or interrupted, then re-started at a slower rate.

Elevation of certain liver enzymes. You will need tests to assess the health of your liver before you receive Hemgenix, and then weekly blood tests to monitor your liver enzymes for 3 months after receiving the infusion. If you have preexisting risk factors for liver cancer, you will receive regular liver health testing for 5 years.

Hemgenix is not intended for administration in women.

How should I take Hemgenix

Your healthcare provider will give you Hemgenix through an intravenous (IV) line.

The amount of time needed for the infusion will depend on your body weight.

Hemgenix can only be administered once.

Your doctor will monitor you for infusion reactions while you are receiving Hemgenix and for at least 3 hours after the infusion is complete. If an infusion reaction occurs, the doctor may slow or stop the infusion, resuming at a lower infusion rate once the symptoms resolve.

Dosing information

Usual Adult Dose for Hemophilia B:

2 x 1013 genome copies (gc) per kg of body weight

Comment:
-administer as an intravenous infusion after dilution with 0.9% normal saline at a constant infusion rate of 500 ml/hour (8 mL/min).

Use:
-treatment of adults with Hemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or who ave current or historical life-threatening hemorrhage, or who have repeated, serious spontaneous bleeding episodes.

Detailed Hemgenix dosage information
Hemgenix Dosage information (more detail)

Before Taking

Before you receive Hemgenix:

  • you will be tested for Factor IX inhibitors. If the test result is positive, a retest will be performed 2 weeks later. You will NOT be able to receive Hemgenix if both tests are positive.
  • you will also be tested to check the health of your liver.
Hemgenix pregnancy and breastfeeding warnings (more detail)

What should I avoid while using Hemgenix?

Small amounts of Hemgenix may be present in your blood, semen, and other excreted/secreted materials, and it is not known how long this continues.

You should not donate blood, organs, tissues, or cells for transplantation after receiving Hemgenix.

Hemgenix side effects

Hemgenix may cause serious side effects.

  • See Important information.

The most common side effects include:

  • liver enzyme elevations
  • headache
  • elevated levels of a certain blood enzyme
  • flu-like symptoms
  • infusion-related reactions
  • fatigue
  • nausea, and
  • feeling unwell.

These are not the only side effects possible. Tell your healthcare provider about any side effect you may experience.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Hemgenix Side Effects

What other drugs will affect Hemgenix?

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

More about Hemgenix (Etranacogene dezaparvovec-drlb)

Dosage information
Hemgenix Side Effects
During pregnancy
Hemgenix Prescribing Information
Drug images
Side effects
Drug class: Miscellaneous uncategorized agents

Related treatment guides

Hemophilia B
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by